氣咽頭炎診斷市場規模、佔有率和成長分析：按產品類型、檢體類型、最終用戶、檢測方法和地區分類－產業預測（2026-2033 年）

2024 年全球 A 型鏈球菌咽頭炎診斷市場價值為 13.6 億美元，預計到 2025 年將成長至 14.7 億美元，到 2033 年將成長至 26.8 億美元，在預測期（2026-2033 年）內複合年成長率為 7.8%。

全球A組鏈球菌咽頭炎診斷市場涵蓋多種技術，包括培養試劑盒、快速抗原檢測和分子診斷平台，所有這些技術都旨在檢測咽喉痛患者體內是否存在A組鏈球菌。該市場的成長主要得益於準確診斷在預防急性風濕熱等疾病以及減少不必要的抗生素處方方面的重要性。對能夠提供即時結果並促進合理使用抗生素的快速照護現場（POC​​）解決方案的需求不斷成長，正推動著檢測方法從傳統培養方法向先進檢測系統的轉變。一個顯著的趨勢是將遠端醫療與診斷檢測結合，從而實現居家分子檢測套組的處方。這種方法提高了醫療服務的可近性，尤其是在農村和學校健康計畫中。領先的製造商正在投資開發與電子健康記錄整合的連接功能，進一步提升了市場的潛力。

全球A組鏈球菌咽頭炎診斷市場促進因素

全球A組鏈球菌咽頭炎診斷市場正受到就地檢驗平台技術的顯著推動，這些平台能夠在臨床環境中直接快速且準確地檢測A組鏈球菌咽頭炎。這項創新縮短了檢測結果的獲取時間，使醫護人員能夠立即做出治療決策。對於希望最佳化患者就診流程並減少對檢查室服務依賴的基層醫療醫生而言，這項技術正變得越來越有吸引力。快速提供檢測結果可以提高患者滿意度和治療方案的依從性，最終增強患者對診斷方案的信心。此外，報告工具的引入提高了數據的可近性，促進了各種醫療機構的臨床應用。

限制全球A組鏈球菌咽頭炎診斷市場的因素

全球A組鏈球菌咽頭炎診斷市場面臨嚴峻挑戰，主要原因是各地健保報銷政策不盡相同，這給考慮投資診斷技術的醫療專業人員帶來了不確定性。當醫保覆蓋不穩定或不足時，臨床醫生往往會轉而採用傳統的、成本較低的培養方法，從而限制了新型高效檢測平台的應用。這種財務上的不確定性阻礙了醫院對先進診斷工具的投資，進而影響了市場滲透率。因此，缺乏標準化的報銷框架限制了技術的普及，迫使醫療機構在財務壓力下優先考慮成本效益高的解決方案，最終阻礙了整體市場成長。解決這些政策上的不一致，並使醫保覆蓋與診斷技術的進步相匹配，可以緩解這一問題。

全球A群鏈球菌咽頭炎診斷市場趨勢

全球A組鏈球菌咽頭炎診斷市場正呈現照護現場（POC​​）診斷快速擴張的顯著趨勢。這一趨勢的主要驅動力是人們對快速準確診斷結果日益成長的需求，以便即時對患者進行治療。為此，製造商正致力於開發適用於診所、學校和職場等各種環境的緊湊型、方便用戶使用的POC平台。這些創新設備將使醫護人員能夠在幾分鐘內檢測出A組鏈球菌，從而實現及時治療決策並最大限度地減少對中心檢查室的依賴。這些診斷設備帶來的便利性和快速結果正在改變醫療流程，並加速床邊檢測在已開發市場和新興市場的普及。最終，這將有助於公共衛生工作，並有助於改善患者的整體治療效果。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 一手數據和二手數據的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 行業概覽
• 競爭環境概述

市場動態與展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

主要市場因素

• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球A組鏈球菌咽頭炎診斷市場規模：依產品類型分類

• 快速抗原檢測（RADT）
• 分子診斷測試
• 培養試驗

全球A組鏈球菌咽頭炎診斷市場規模：依檢體類型分類

• 咽拭子
• 其他檢體

全球A組鏈球菌咽頭炎診斷市場規模：依最終用戶分類

• 醫院
• 診斷實驗室
• 醫生辦公室/診所
• 照護現場環境

全球A組鏈球菌咽頭炎診斷市場規模：依檢測方法分類

• 臨床試驗
• 就地檢驗

全球A鏈球菌咽頭炎診斷市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• bioMerieux SA
• QIAGEN NV
• Hologic, Inc.
• Becton, Dickinson and Company
• QuidelOrtho Corporation
• Sekisui Diagnostics, LLC
• Trinity BIoTech plc
• DiaSorin SpA
• Sysmex Corporation
• OraSure Technologies, Inc.
• EKF Diagnostics Holdings plc
• SD Biosensor, Inc.
• ACON Laboratories, Inc.
• Arkray, Inc.
• Luminex Corporation

結論與建議

Global Gas Pharyngitis Diagnostics Market size was valued at USD 1.36 Billion in 2024 and is poised to grow from USD 1.47 Billion in 2025 to USD 2.68 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global GAS pharyngitis diagnostics market encompasses a range of technologies aimed at detecting Group A Streptococcus in patients experiencing sore throat, including culture kits, rapid antigen tests, and molecular platforms. The market's growth is driven by the importance of accurate diagnostics in preventing conditions such as acute rheumatic fever and reducing unnecessary antibiotic prescriptions. The demand for rapid point-of-care solutions, which provide immediate results and promote antibiotic stewardship, has led to a shift from traditional culture methods to advanced testing systems. A notable trend is the integration of telemedicine with diagnostic testing, allowing for the prescription of at-home molecular kits. This approach enhances accessibility, especially in rural areas and school health programs, leading manufacturers to invest in connectivity features that integrate with electronic health records, thus boosting market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gas Pharyngitis Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gas Pharyngitis Diagnostics Market Segments Analysis

Global gas pharyngitis diagnostics market is segmented by product type, sample type, end user, testing mode and region. Based on product type, the market is segmented into rapid antigen detection tests (RADTs), molecular diagnostic tests and culture-based tests. Based on sample type, the market is segmented into throat swab and other specimens. Based on end user, the market is segmented into hospitals, diagnostic laboratories, physician offices & clinics and point-of-care settings. Based on testing mode, the market is segmented into laboratory testing and point-of-care testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gas Pharyngitis Diagnostics Market

The Global Gas Pharyngitis Diagnostics market is significantly driven by the advancements in point-of-care testing platforms, which facilitate rapid and accurate detection of GAS pharyngitis directly in clinical environments. This innovation shortens the turnaround time for results, allowing healthcare providers to make immediate treatment decisions, which is increasingly appealing to primary care practitioners aiming to optimize patient flow and lessen reliance on laboratory services. The swift delivery of results enhances patient satisfaction and compliance with treatment protocols, thereby building trust in diagnostic solutions. Additionally, the incorporation of reporting tools improves data accessibility, promoting broader clinical adoption across various healthcare settings.

Restraints in the Global Gas Pharyngitis Diagnostics Market

The Global Gas Pharyngitis Diagnostics market faces significant challenges due to inconsistent reimbursement policies across different regions, creating uncertainty among healthcare providers when considering investments in diagnostic technologies. When insurance coverage is unreliable or lacking, clinicians are likely to revert to traditional, less expensive culture methods, which restricts the adoption of newer and more efficient testing platforms. This financial ambiguity discourages hospitals from investing in advanced diagnostic tools, impeding market penetration. As a result, the absence of standardized reimbursement frameworks limits widespread adoption, forcing providers to prioritize cost-effective solutions in financially constrained environments, thus hindering overall market growth. Addressing these policy discrepancies to align coverage with diagnostic advancements could help mitigate this issue.

Market Trends of the Global Gas Pharyngitis Diagnostics Market

The Global Gas Pharyngitis Diagnostics market is witnessing a significant trend towards the expansion of point-of-care (POC) diagnostics. This shift is primarily driven by the increasing need for rapid, accurate diagnostic results that enable immediate patient management. Manufacturers are responding by developing compact and user-friendly POC platforms suitable for deployment in various settings, such as clinics, schools, and workplaces. These innovative devices allow healthcare providers to detect group A streptococcus within minutes, facilitating timely treatment decisions and minimizing the dependence on centralized laboratories. The enhanced convenience and swift turnaround times of these diagnostics are transforming care pathways, promoting wider adoption of bedside testing across both developed and emerging markets, and ultimately supporting public health initiatives while improving overall patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global GAS Pharyngitis Diagnostics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Rapid Antigen Detection Tests (RADTs)
• Molecular Diagnostic Tests
• Culture-Based Tests

Global GAS Pharyngitis Diagnostics Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Throat Swab
• Other Specimens

Global GAS Pharyngitis Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Physician Offices & Clinics
• Point-of-Care Settings

Global GAS Pharyngitis Diagnostics Market Size by Testing Mode & CAGR (2026-2033)

• Market Overview
• Laboratory Testing
• Point-of-Care Testing

Global GAS Pharyngitis Diagnostics Market Size & CAGR (2026-2033)

• North America (Product Type, Sample Type, End User, Testing Mode)
  • US
  • Canada
• Europe (Product Type, Sample Type, End User, Testing Mode)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Sample Type, End User, Testing Mode)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Sample Type, End User, Testing Mode)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Sample Type, End User, Testing Mode)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations